CHICAGO (AP) — The University of Illinois Chicago has received a $6 million from the federal government to test a potential drug to treat COVID-19.
Researchers say the drug candidate, called VT-109, has been shown to help restore function to damaged lungs, among other things. The drug will be tested in pre-clinical animal models of COVID-19 to determine efficacy and toxicity before human trials are considered.
The money is a technology and therapeutic development award from the U.S. Department of Defense.
I am text block. Click edit button to change this text. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.
